NS
Article DetailSEC EDGAR Filings
首页文档检索台
SEC EDGAR Filings

8-K - Q32 Bio Inc. - 8.01 / 9.01

Filed: 2026-04-24 AccNo: 0001193125-26-177178 Size: 156 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
查看原文来源主页查看事件簇按来源查看
发布时间04/24 20:09 UTC
首次发现04/24 20:13 UTC
热度104.0
重要度52
情绪0.00

站内整理正文

优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 699 字符

Form 8-K - Current report: SEC Accession No. 0001193125-26-177178

Filing Date: 2026-04-24

Accepted: 2026-04-24 16:09:18

Documents: 13

Period of Report: 2026-04-24

Items: Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Q32 Bio Inc. (Filer) CIK : 0001661998 (see all company filings) EIN. : 473468154 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-38433 | Film No.: 26893787 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)

1 | 8-K | d31430d8k.htm iXBRL | 8-K

2 | EX-5.1 | d31430dex51.htm | EX-5.1

6 | GRAPHIC | g31430g0425004124962.jpg | GRAPHIC

3 | XBRL TAXONOMY EXTENSION SCHEMA | qttb-20260424.xsd | EX-101.SCH